KaydedilenlerDerginizi ekleyin

Dergiler / Eurasian Journal of Pulmonology / 2021 / Cilt: 23 - Sayı: 1

Current challenges and future scope of nanoparticles in chronic obstructive pulmonary disease

Surya Kant
Ajay Kumar Verma
Sarika Pandey
Rajiv Garg
Priyanka Gaur
Megha Agarwal
Sayfa
10–13
Yayın Tarihi
2022-10-18
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Development of multifunctional biodegradable NPs that are nontoxic and can help in overcoming airway defense will be beneficial in future for COPD.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Chronic obstructive pulmonary disease (COPD), characterized by airway inflammation and progressive airflow limitation, is one of the leading causes of mortality worldwide.
📊
Temel Bulgular & Veri:Bronchodilators, corticosteroids, or antibiotics are used for treatment of COPD, but the drugs are not delivered properly to the target cells or a tissue, which remains a challenge.
💡
Sonuç & Katkı:Development of multifunctional biodegradable NPs that are nontoxic and can help in overcoming airway defense will be beneficial in future for COPD.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Abstract

Chronic obstructive pulmonary disease (COPD), characterized by airway inflammation and progressive airflow limitation, is one of the leading causes of mortality worldwide. Bronchodilators, corticosteroids, or antibiotics are used for treatment of COPD, but the drugs are not delivered properly to the target cells or a tissue, which remains a challenge. Nanoparticles (NPs) have gained a tremendous interest in respiratory medicine due to their smaller size, higher surface to volume ratio, and advantages such as targeting effects, patient compliance, and improved pharmacotherapy. Sustained delivery of drugs mediated by NPs to the targeted site is needed to control cell chemotaxis, fibrosis, and chronic obstruction of lungs in COPD. Development of multifunctional biodegradable NPs that are nontoxic and can help in overcoming airway defense will be beneficial in future for COPD.

🔖

Bu Makaleye Atıf Yap

Kant, S., Verma, A. K., Pandey, S., Garg, R., Gaur, P., Agarwal, M. (2022). Current challenges and future scope of nanoparticles in chronic obstructive pulmonary disease. Eurasian Journal of Pulmonology, Cilt: 23 - Sayı: 1, 10–13. https://ajindex.com/articles/509555

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (16)

  1. Global Initiative for Chronic Obstructive Lung Disease. Global Strategy for the Diagnosis, Management and Prevention of COPD. Global Initiative for Chronic Obstructive Lung Disease; 2014. Available from: http://www.gold copd.org/. [Last accessed on 2018 May 11]
  2. Hogg JC, Chu F, Utokaparch S, Woods R, Elliott WM, Buzatu L, et al. The nature of small‑airway obstruction in chronic obstructive pulmonary disease. N Engl J Med 2004;350:2645‑53
  3. Vij N. Nano‑based theranostics for chronic obstructive lung diseases: Challenges and therapeutic potential. Expert Opin Drug Deliv 2011;8:1105‑9
  4. Dua K, Shukla SD, de Jesus Andreoli Pinto T, Hansbro PM. Nanotechnology: Advancing the translational respiratory research. Interv Med Appl Sci 2017;9:39‑41
  5. Agarwal M, Agarwal MK, Shrivastav N, Pandey S, Das R, Gaur P. Preparation of chitosan nanoparticles and their in‑vitro characterization. Int J Life Sci Sci Res 2018;4:1713‑20
  6. Bailey MM, Berkland CJ. Nanoparticle formulations in pulmonary drug delivery. Med Res Rev 2009;29:196‑212
  7. Torchilin VP. Recent advances with liposomes as pharmaceutical carriers. Nat Rev Drug Discov 2005;4:145‑60
  8. Paranjpe M, Müller‑Goymann CC. Nanoparticle‑mediated pulmonary drug delivery: A review. Int J Mol Sci 2014;15:5852‑73
  9. Kingsley JD, Dou H, Morehead J, Rabinow B, Gendelman HE, Destache CJ. Nanotechnology: A focus on nanoparticles as a drug delivery system. J Neuroimmune Pharmacol 2006;1:340‑50
  10. Upadhyay S, Ganguly K, Palmberg L. Wonders of nanotechnology in the treatment for chronic lung diseases. J Nanomed Nanotechnol 2015;6:337
  11. Roy I, Vij N. Nanodelivery in airway diseases: Challenges and therapeutic applications. Nanomedicine 2010;6:237‑44
  12. Barnes PJ, Shapiro SD, Pauwels RA. Chronic obstructive pulmonary disease: Molecular and cellular mechanisms. Eur Respir J 2003;22:672‑88
  13. Soppimath KS, Aminabhavi TM, Kulkarni AR, Rudzinski WE. Biodegradable polymeric nanoparticles as drug delivery devices. J Control Release 2001;70:1‑20
  14. Tan W, Wang K, He X, Zhao XJ, Drake T, Wang L, et al. Bionanotechnology based on silica nanoparticles. Med Res Rev 2004;24:621‑38
  15. Stroh M, Zimmer JP, Duda DG, Levchenko TS, Cohen KS, Brown EB, et al. Quantum dots spectrally distinguish multiple species within the tumor milieu in vivo. Nat Med 2005;11:678‑82
  16. Michalet X, Pinaud FF, Bentolila LA, Tsay JM, Doose S, Li JJ, et al. Quantum dots for live cells, in vivo imaging, and diagnostics. Science 2005;307:538‑44.